UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Impact of COVID-19 pandemic control measures on infection of other respiratory pathogens: A real-world data research in Guangzhou, China Journal article
Haisheng Hu, Xiangqing Hou, Jiajia Wu, Lixian Li, Huimin Huang, Zhangkai Jason Cheng, Peiyan Zheng, Baoqing Sun. Impact of COVID-19 pandemic control measures on infection of other respiratory pathogens: A real-world data research in Guangzhou, China[J]. Journal of Translational Internal Medicine, 2022, 10(3), 272-276.
Authors:  Haisheng Hu;  Xiangqing Hou;  Jiajia Wu;  Lixian Li;  Huimin Huang; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:4.7/3.8 | Submit date:2023/01/30
Smoking: a leading factor for the death of chronic respiratory diseases derived from Global Burden of Disease Study 2019 Journal article
Hui Gan, Xiangqing Hou, Zheng Zhu, Mingshan Xue, Teng Zhang, Zhifeng Huang, Zhangkai Jason Cheng, Baoqing Sun. Smoking: a leading factor for the death of chronic respiratory diseases derived from Global Burden of Disease Study 2019[J]. BMC Pulmonary Medicine, 2022, 22(1), 149.
Authors:  Hui Gan;  Xiangqing Hou;  Zheng Zhu;  Mingshan Xue;  Teng Zhang; et al.
Favorite | TC[WOS]:19 TC[Scopus]:18  IF:2.6/3.0 | Submit date:2022/05/13
Chronic Respiratory Disease  Global Disease Burden  Particulate Matter Pollution  Smoking  
Clinical utility of heparin-binding protein as an acute-phase inflammatory marker in interstitial lung disease Journal article
Xue, Mingshan, Zhang, Teng, Lin, Runpei, Zeng, Yifeng, Cheng, Zhangkai Jason, Li, Ning, Zheng, Peiyan, Huang, Huimin, Zhang, Xiaohua Douglas, Wang, Hongman, Sun, Baoqing. Clinical utility of heparin-binding protein as an acute-phase inflammatory marker in interstitial lung disease[J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2022, 112(4), 861-873.
Authors:  Xue, Mingshan;  Zhang, Teng;  Lin, Runpei;  Zeng, Yifeng;  Cheng, Zhangkai Jason; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:3.6/5.2 | Submit date:2022/05/17
Ae-ild  Ctd-ild  Heparin-binding Protein  Ipf  
Integrative omics analysis identifies biomarkers of idiopathic pulmonary fibrosis Journal article
Zheng, Peiyan, Sun, Shixue, Wang, Jingxian, Cheng, Zhangkai Jason, Lei, Kuan Cheok, Xue, Mingshan, Zhang, Teng, Huang, Huimin, Zhang, Xiaohua Douglas, Sun, Baoqing. Integrative omics analysis identifies biomarkers of idiopathic pulmonary fibrosis[J]. Cellular and Molecular Life Sciences, 2022, 79(1), 66.
Authors:  Zheng, Peiyan;  Sun, Shixue;  Wang, Jingxian;  Cheng, Zhangkai Jason;  Lei, Kuan Cheok; et al.
Favorite | TC[WOS]:8 TC[Scopus]:10  IF:6.2/7.7 | Submit date:2022/02/21
Aec Injury  Immune Responses  Multi-omics Analysis  Myofibroblast Proliferation  Whole-genome Expression  
Public Health Measures and the Control of COVID-19 in China Journal article
Zhangkai Jason Cheng, Zhiqing Zhan, Mingshan Xue, Peiyan Zheng, Jiali Lyu, Jing Ma, Xiaohua Douglas Zhang, Wenting Luo, Huimin Huang, Yong Zhang, Hongman Wang, Nanshan Zhong, Baoqing Sun. Public Health Measures and the Control of COVID-19 in China[J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2021, 64, 1-16.
Authors:  Zhangkai Jason Cheng;  Zhiqing Zhan;  Mingshan Xue;  Peiyan Zheng;  Jiali Lyu; et al.
Favorite | TC[WOS]:57 TC[Scopus]:58  IF:8.4/10.2 | Submit date:2022/05/13
China  Covid-19 Pandemic  Infection Control And Management  Public Health  
Factors affecting the antibody immunogenicity of vaccines against sars-cov-2: A focused review Review article
2021
Authors:  Cheng, Zhangkai Jason;  Xue, Mingshan;  Zheng, Peiyan;  Lyu, Jiali;  Zhan, Zhiqing; et al.
Favorite | TC[WOS]:16 TC[Scopus]:16  IF:5.2/4.9 | Submit date:2021/12/08
Ade  Covid-19  Neutralizing Antibody  Vaccines  Variants